Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Clinical and Experimental Medicine|October 3, 2024
Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapiesJoanna Ciepła, Ryszard SmolarczykScientific Reports|March 17, 2026
Characteristics of NK cells activation following IL-12, IL-15, IL-18 cytokines stimulation for preclinical purposesJustyna Czapla, Alina Drzyzga, Ryszard SmolarczykPostepy Higieny I Medycyny Doswiadczalnej (Online)|August 1, 2009
[Peptides: a new class of anticancer drugs]Ryszard Smolarczyk, Tomasz Cichoń, Stanisław SzalaAnticancer Research|July 11, 2006
Plasmid DNA-induced cytokines together with cyclophosphamide decrease size and number of melanoma lung metastasesTomasz Cichon, Ryszard Smolarczyk, Aleksander Sochanik, et al.Postepy Higieny I Medycyny Doswiadczalnej (Online)|November 24, 2012
[HMGB1--its role in tumor progression and anticancer therapy]Ryszard Smolarczyk, Tomasz Cichoń, Magdalena Jarosz, et al.Cytokine|March 8, 2005
Negligible induction of IFN-gamma, IL-12 and TNF-alpha by DNA-PEI 750 kDa/albumin complexesRyszard Smolarczyk, Tomasz Cichoń, Aleksander Sochanik, et al.Postepy Higieny I Medycyny Doswiadczalnej (Online)|November 24, 2012
["Vicious circles" of glioblastoma tumors: vascularization and invasiveness]Stanisław Szala, Magdalena Jarosz, Ryszard Smolarczyk, et al.International Journal of Molecular Sciences|July 3, 2019
Tumor Microenvironment as A "Game Changer" in Cancer RadiotherapyMagdalena Jarosz-Biej, Ryszard Smolarczyk, Tomasz Cichoń, et al.European Journal of Pharmacology|November 1, 2020
Vascular disrupting agents in cancer therapyRyszard Smolarczyk, Justyna Czapla, Magdalena Jarosz-Biej, et al.Archivum Immunologiae Et Therapiae Experimentalis|February 4, 2014
D-K6L 9 peptide combination with IL-12 inhibits the recurrence of tumors in miceTomasz Cichoń, Ryszard Smolarczyk, Sybilla Matuszczak, et al.Pageof 6